Alan W Dunton - Net Worth and Insider Trading
Alan W Dunton Net Worth
The estimated net worth of Alan W Dunton is at least $163,012 dollars as of 2024-04-29. Alan W Dunton is the Director of Palatin Technologies Inc and owns about 45,074 shares of Palatin Technologies Inc (PTN) stock worth over $82,035. Alan W Dunton is the Director of Cormedix Inc and owns about 15,250 shares of Cormedix Inc (CRMD) stock worth over $80,978. Alan W Dunton is also the Director of Catalyst Biosciences Inc and owns about 0 shares of Catalyst Biosciences Inc (CBIO) stock worth over $0. Details can be seen in Alan W Dunton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alan W Dunton has not made any transactions after 2023-12-15 and currently still holds the listed stock(s).
Transaction Summary of Alan W Dunton
Alan W Dunton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alan W Dunton owns 6 companies in total, including Cormedix Inc (CRMD) , Palatin Technologies Inc (PTN) , and Oragenics Inc (OGEN) among others .
Click here to see the complete history of Alan W Dunton’s form 4 insider trades.
Insider Ownership Summary of Alan W Dunton
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CRMD | Cormedix Inc | 2023-12-15 | director |
PTN | Palatin Technologies Inc | 2023-12-04 | director |
OGEN | Oragenics Inc | 2015-12-15 | director |
CBIO | Catalyst Biosciences Inc | 2015-08-04 | director |
IMNPQ | Immune Pharmaceuticals Inc | 2013-08-12 | director |
MNOV | MediciNova Inc | 2006-05-11 | director |
Alan W Dunton Latest Holdings Summary
Alan W Dunton currently owns a total of 3 stocks. Among these stocks, Alan W Dunton owns 45,074 shares of Palatin Technologies Inc (PTN) as of December 4, 2023, with a value of $82,035 and a weighting of 50.32%. Alan W Dunton owns 15,250 shares of Cormedix Inc (CRMD) as of December 15, 2023, with a value of $80,978 and a weighting of 49.68%. Alan W Dunton also owns 0 shares of Catalyst Biosciences Inc (CBIO) as of August 2, 2010, with a value of $0 and a weighting of 0%.
Latest Holdings of Alan W Dunton
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PTN | Palatin Technologies Inc | 2023-12-04 | 45,074 | 1.82 | 82,035 |
CRMD | Cormedix Inc | 2023-12-15 | 15,250 | 5.31 | 80,978 |
CBIO | Catalyst Biosciences Inc | 2010-08-02 | 0 | 7.67 | 0 |
Holding Weightings of Alan W Dunton
Alan W Dunton Form 4 Trading Tracker
According to the SEC Form 4 filings, Alan W Dunton has made a total of 2 transactions in Palatin Technologies Inc (PTN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Palatin Technologies Inc is the sale of 200 shares on December 4, 2023, which brought Alan W Dunton around $496.
According to the SEC Form 4 filings, Alan W Dunton has made a total of 3 transactions in Cormedix Inc (CRMD) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Cormedix Inc is the acquisition of 6,000 shares on December 15, 2023, which cost Alan W Dunton around $20,280.
According to the SEC Form 4 filings, Alan W Dunton has made a total of 0 transactions in Catalyst Biosciences Inc (CBIO) over the past 5 years. The most-recent trade in Catalyst Biosciences Inc is the sale of 57 shares on August 2, 2010, which brought Alan W Dunton around $133,800.
Insider Trading History of Alan W Dunton
- 1
Alan W Dunton Trading Performance
GuruFocus tracks the stock performance after each of Alan W Dunton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alan W Dunton is 15.63%. GuruFocus also compares Alan W Dunton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alan W Dunton within 3 months outperforms 8 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alan W Dunton's insider trading performs compared to the benchmark.
Performance of Alan W Dunton
Average Return
44.78%
Outperforming Transactions
100%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 11.65 | 15.63 | 52.52 | 44.78 | 16.06 | 3.6 |
Relative Return to S&P 500(%) | 10.57 | 11.1 | 43.52 | 27.1 | -1.05 | -9.62 |
Alan W Dunton Ownership Network
Ownership Network List of Alan W Dunton
Ownership Network Relation of Alan W Dunton
Alan W Dunton Owned Company Details
What does Cormedix Inc do?
Who are the key executives at Cormedix Inc?
Alan W Dunton is the director of Cormedix Inc. Other key executives at Cormedix Inc include director & Chief Executive Officer Joseph Todisco , Chief Commercial Officer Erin Mistry , and EVP & Chief Financial Officer Matthew T David .
Cormedix Inc (CRMD) Insider Trades Summary
Over the past 18 months, Alan W Dunton made 2 insider transaction in Cormedix Inc (CRMD) with a net purchase of 9,000. Other recent insider transactions involving Cormedix Inc (CRMD) include a net purchase of 48,561 shares made by Joseph Todisco , a net purchase of 10,000 shares made by Paulo F Costa , and a net purchase of 10,000 shares made by Robert A Stewart .
In summary, during the past 3 months, insiders sold 0 shares of Cormedix Inc (CRMD) in total and bought 13,561 shares, with a net purchase of 13,561 shares. During the past 18 months, 0 shares of Cormedix Inc (CRMD) were sold and 84,561 shares were bought by its insiders, resulting in a net purchase of 84,561 shares.
Cormedix Inc (CRMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cormedix Inc Insider Transactions
Alan W Dunton Mailing Address
Above is the net worth, insider trading, and ownership report for Alan W Dunton. You might contact Alan W Dunton via mailing address: Vicuron Pharmaceuticals Inc, 455 S Gulph Road Suite 305, King Of Prussia Pa 19406.